COMPANY PROFILE // THE 014 REPORT
Black Hawk Acquisition Corp
BKHA (Nasdaq) · BKHAR (Nasdaq) · BKHAU (Nasdaq)
Assembled from 2 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberNT 10-Q filed on 2026-04-14: notice that a periodic report would be late (3 such notices in 24 months).
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-04-01 (last 24 months).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Black Hawk Acquisition Corp is an SEC-registered operating company in biological products, (no diagnostic substances), based in Danville, CA; listed as BKHA (Nasdaq), BKHAR (Nasdaq), BKHAU (Nasdaq).[source] It has filed 37 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are MIZUHO SECURITIES USA LLC, WOLVERINE ASSET MANAGEMENT LLC, BERKLEY W R CORP (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; NT 10-Q filed on 2026-04-14.[source]
- red0
- amber2
- info0
- MIZUHO SECURITIES USA LLC$8.6M
- WOLVERINE ASSET MANAGEMENT LLC$3.9M
- BERKLEY W R CORP$3.9M
- AQR Arbitrage LLC$1.6M
- BOOTHBAY FUND MANAGEMENT, LLC$1.4M
- Westchester Capital Management, LLC$1.2M
- Yakira Capital Management, Inc.$1.1M
- Clear Street Group Inc.$970K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Legal counsel, as publicly named
- Celine and Partners PLLC · Exhibit 5.1 legal opinion, S-1 filed 2024-02-05
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0002000775 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 4125 BLACKHAWK PLAZA CIRCLE, DANVILLE, CA, 94506 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-02-28 · in 100 days · Next 10-K due (period ended 2026-11-30; <br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-04-14 · in 145 days · Next 10-Q due (period ended 2027-02-28; <br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- AMGEN INC · 123 SEC filings in 12 months · 1 flag · $507.4M federal (possible match)
- Vir Biotechnology, Inc. · 117 SEC filings in 12 months · 1 flag · $65.9M federal (possible match)
- Vericel Corp · 109 SEC filings in 12 months · 1 flag · $37.3M federal (possible match)
- Coherus Oncology, Inc. · 53 SEC filings in 12 months · 3 flags · $11.8M federal (possible match)
- BIO-TECHNE Corp · 77 SEC filings in 12 months · 1 flag · $6.6M federal (possible match)
- Twist Bioscience Corp · 337 SEC filings in 12 months · 2 flags · $5.9M federal (possible match)
- Adaptive Biotechnologies Corp · 185 SEC filings in 12 months · 1 flag · $1.9M federal (possible match)
- AGENUS INC · 82 SEC filings in 12 months · 3 flags · $613K federal (possible match)
- REPLIGEN CORP · 89 SEC filings in 12 months · 1 flag · $457K federal (possible match)
- Revolution Medicines, Inc. · 171 SEC filings in 12 months · 2 flags · $15K federal (possible match)
- RECURSION PHARMACEUTICALS, INC. · 174 SEC filings in 12 months · 1 flag
- GILEAD SCIENCES, INC. · 173 SEC filings in 12 months
ADDRESS · ZIP CODE
Location context
At the same address (3)
- NP Life Sciences Health Industry Group Inc. · SEC registrant
- Bodhi Tree Biotechnology Inc · SEC registrant
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
SEC registrants at the same address
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-23 filing 8-K items 8.01 · SEC EDGAR
- 2026-10-13 filing 8-K items 5.07 · SEC EDGAR
- 2026-10-06 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-09-25 filing 425 · SEC EDGAR
- 2026-09-24 filing 8-K items 1.01,3.02,9.01 · SEC EDGAR
- 2026-09-22 filing 8-K items 8.01 · SEC EDGAR
- 2026-09-22 filing 424B4 · SEC EDGAR
- 2026-09-17 filing EFFECT · SEC EDGAR
- 2026-09-04 filing S-4/A · SEC EDGAR
- 2026-08-26 filing 8-K items 1.01,2.03,3.02,9.01 · SEC EDGAR
- 2026-08-25 filing 8-K items 8.01 · SEC EDGAR
- 2026-08-03 filing S-4/A · SEC EDGAR
- 2026-07-22 filing 8-K items 8.01 · SEC EDGAR
- 2026-07-15 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-07-06 filing S-4/A · SEC EDGAR
- 2026-06-11 filing S-4/A · SEC EDGAR
- 2026-05-08 filing 8-K items 1.01,2.03,3.02,9.01 · SEC EDGAR
- 2026-05-01 filing S-4/A · SEC EDGAR
- 2026-04-28 filing 10-K/A · SEC EDGAR
- 2026-04-21 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-04-14 filing NT 10-Q · SEC EDGAR
- 2026-04-01 filing 8-K items 3.01 · SEC EDGAR
- 2026-03-17 officer change 8-K items 5.02,7.01,9.01 · SEC EDGAR
- 2026-03-06 filing Annual report (10-K) · SEC EDGAR
- 2026-03-05 filing S-4/A · SEC EDGAR
- 2026-03-02 filing NT 10-K · SEC EDGAR
- 2026-02-19 filing 8-K items 1.01,2.03,3.02,9.01 · SEC EDGAR
- 2026-02-03 officer change 8-K items 5.02 · SEC EDGAR
- 2026-01-26 filing S-4/A · SEC EDGAR
- 2026-01-23 filing S-4/A · SEC EDGAR
58 earlier entries
- 2025-12-29 filing DEL AM
- 2025-12-23 filing S-4
- 2025-10-21 filing Quarterly report (10-Q)
- 2025-10-15 filing NT 10-Q
- 2025-09-24 filing 8-K items 8.01
- 2025-09-23 filing DRS/A
- 2025-08-28 filing 8-K items 8.01
- 2025-08-08 filing 8-K items 8.01
- 2025-08-04 filing DRS/A
- 2025-07-22 filing 8-K/A items 8.01
- 2025-07-14 filing 8-K items 1.01,5.03,5.07,8.01,9.01
- 2025-07-08 filing DEFA14A
- 2025-07-08 filing 8-K items 8.01,9.01
- 2025-07-03 filing 8-K items 8.01
- 2025-07-01 filing 8-K items 8.01
- 2025-06-27 filing 8-K items 8.01
- 2025-06-26 filing Quarterly report (10-Q)
- 2025-06-24 filing 8-K items 8.01
- 2025-06-23 filing 8-K items 8.01
- 2025-06-20 filing 8-K items 8.01,9.01
- 2025-06-20 filing DEFA14A
- 2025-06-20 filing 8-K items 8.01
- 2025-06-20 filing DEFA14A
- 2025-06-12 filing DRS
- 2025-06-10 filing DEFR14A
- 2025-06-10 filing Proxy statement
- 2025-06-04 officer change 8-K items 5.02
- 2025-05-28 filing PRE 14A
- 2025-04-29 filing 425
- 2025-04-29 filing 8-K items 1.01,9.01
- 2025-04-11 filing 10-K/A
- 2025-04-10 filing Quarterly report (10-Q)
- 2025-02-07 filing Annual report (10-K)
- 2024-09-23 filing Quarterly report (10-Q)
- 2024-06-28 filing Quarterly report (10-Q)
- 2024-04-26 filing SC 13D
- 2024-04-24 officer change 8-K/A items 5.02,8.01,9.01
- 2024-04-24 officer change 8-K items 5.02,8.01,9.01
- 2024-04-19 filing Quarterly report (10-Q)
- 2024-04-04 filing 8-K/A items 8.01
- 2024-04-01 filing SC 13D
- 2024-03-28 filing 8-K items 8.01,9.01
- 2024-03-26 filing 8-K items 1.01,3.02,5.03,8.01,9.01
- 2024-03-22 filing 424B4
- 2024-03-21 filing CERT
- 2024-03-20 filing EFFECT
- 2024-03-20 filing S-1MEF
- 2024-03-20 filing 8-A12B
- 2024-03-15 filing CORRESP
- 2024-03-15 filing CORRESP
- 2024-03-08 filing S-1/A
- 2024-02-26 filing S-1/A
- 2024-02-23 filing CORRESP
- 2024-02-21 filing UPLOAD
- 2024-02-05 filing Registration (S-1)
- 2024-02-02 filing CORRESP
- 2024-01-17 filing UPLOAD
- 2023-12-21 filing DRS
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-23 (within 30 days) 8-K filed: Item 8.01 other event
- 2026-10-13 (older) 8-K filed: Item 5.07 shareholder vote
- 2026-10-06 (older) 10-Q filed
- 2026-09-25 (older) 425 filed
- 2026-09-24 (older) 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-09-22 (older) 8-K filed: Item 8.01 other event
- 2026-09-22 (older) 424B4 filed
- 2026-09-17 (older) EFFECT filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-19; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:BKHA The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 2000775 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | BKHA / Nasdaq, Nasdaq, Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | G1148A101 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0002000775 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-11-30) | $1,329,557 | 2025-11-30 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-19 19:23 UTC | Report an error |
| Total assets (at 2025-11-30) | $23,877,939 | 2025-11-30 | 10-K, XBRL Assets | as filed | 2026-11-19 19:23 UTC | Report an error |
| Stockholders' equity (at 2025-11-30) | -$3,846,443 | 2025-11-30 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-19 19:23 UTC | Report an error |
| Cash and cash equivalents (at 2025-11-30) | $0 | 2025-11-30 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-19 19:23 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 19:23 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 19:23 UTC | Report an error |
| Fiscal year end (MMDD) | 1130 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 19:23 UTC | Report an error |
| Business address | 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE, CA, 94506 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 19:23 UTC | Report an error |
| Exchanges | Nasdaq, Nasdaq, Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 19:23 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-11-30) | -$650,321 | 2025-11-30 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-19 19:23 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-08-31, filed 2026-10-06 · accession 0001829126-26-010813
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $1,074,736 | 3 months ended 2026-08-31 | 10-Q | 2026-10-06 | 0001829126-26-010813 | 2026-11-19 19:23 UTC | Report an error |
| Interest expense | $33,226 | 3 months ended 2026-08-31 | 10-Q | 2026-10-06 | 0001829126-26-010813 | 2026-11-19 19:23 UTC | Report an error |
| Cash and cash equivalents | $0 | at 2026-08-31 | 10-Q | 2026-10-06 | 0001829126-26-010813 | 2026-11-19 19:23 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-23 Filing 8-K filed: Item 8.01 other event
- 2026-10-13 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-10-06 Filing 10-Q filed
- 2026-09-25 Filing 425 filed
- 2026-09-24 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-09-22 Filing 8-K filed: Item 8.01 other event
- 2026-09-22 Filing 424B4 filed
- 2026-09-17 Filing EFFECT filed
- 2026-09-04 Filing S-4/A filed
- 2026-08-26 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-08-25 Filing 8-K filed: Item 8.01 other event
- 2026-08-03 Filing S-4/A filed
- 2026-07-22 Filing 8-K filed: Item 8.01 other event
- 2026-07-15 Filing 10-Q filed
- 2026-07-06 Filing S-4/A filed
- 2026-06-11 Filing S-4/A filed
- 2026-05-08 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-05-01 Filing S-4/A filed
- 2026-04-28 Filing 10-K/A filed
- 2026-04-21 Filing 10-Q filed
- 2026-04-14 Filing NT 10-Q filed
- 2026-04-01 Filing 8-K filed: Item 3.01 delisting notice
- 2026-03-17 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-03-06 Filing 10-K filed
- 2026-03-05 Filing S-4/A filed
8-K item text, as filed (excerpts)
- 2026-10-23 8-K Item 8.01, Other Events
On October 22, 2026, an aggregate of $150,000 (the “Extension Payment”) was deposited into the trust account of Black Hawk Acquisition Corporation (the “Company”) for its public shareholders, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from October 22, 2026 to November 22, 2026. 1 the 8-K · retrieved 2026-11-19 19:23 UTC - 2026-10-13 8-K Item 5.07, Submission of a Matter to a Vote of Security Holders
On October 13, 2026, Black Hawk Acquisition Corporation (the “Company”) held an extraordinary general meeting of Shareholders (the “Extraordinary General Meeting”). The record date for shareholders entitled to notice of and to vote at the Extraordinary General Meeting was September 1, 2026. As of the record date, 4,153,577 ordinary shares were issued and outstanding and entitled to vote at the Extraordinary General Meeting. Of these shares, 3,211,516 shares, representing approximately 77.3% of the outstanding ordinary shares entitled to vote, were present by virtually or represented by proxy at the Extraordinary General Meeting, constituting a quorum. At the Extraordinary General Meeting… the 8-K · retrieved 2026-11-19 19:23 UTC - 2026-09-24 8-K Item 1.01, Entry Into a Material Definitive Agreement
On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing and related agreements with Meteora Select Trading Opportunities Master, LP (“Meteora”) in connection with the Company’s previously announced business combination with Vesicor (the “Business Combination”). Pursuant to the Business Combination Agreement, dated April 26, 2025, by and among the Company, BH Merger Sub, Inc. and Vesicor (as amended or otherwise modified from time to time, the “Business Combination Agreement”), the Company will domesticate as a Delaware… the 8-K · retrieved 2026-11-19 19:23 UTC - 2026-09-24 8-K Item 3.02, Unregistered Sales of Equity Securities
The information set forth under Item 1.01 of this Current Report on Form 8-K regarding the Subscription Agreement, the SEPA and the form of convertible promissory note is incorporated herein by reference. The shares of PubCo common stock that may be issued pursuant to the Subscription Agreement and the SEPA, including shares issuable upon conversion of any convertible promissory notes and any shares issued in payment of the commitment fee, have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and are expected to be issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or other applicable… the 8-K · retrieved 2026-11-19 19:23 UTC - 2026-09-22 8-K Item 8.01, Other Events
An aggregate of $150,000 (the “Extension Payment”) has been deposited into the trust account of Black Hawk Acquisition Corporation (the “Company”) for its public shareholders, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from September 22, 2026 to October 22, 2026. 1 the 8-K · retrieved 2026-11-19 19:23 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | MIZUHO SECURITIES USA LLC | $8,597,400 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 2 | WOLVERINE ASSET MANAGEMENT LLC | $3,898,483 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 3 | BERKLEY W R CORP | $3,889,317 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 4 | AQR Arbitrage LLC | $1,566,681 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 5 | BOOTHBAY FUND MANAGEMENT, LLC | $1,429,200 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 6 | Westchester Capital Management, LLC | $1,200,540 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 7 | Yakira Capital Management, Inc. | $1,057,001 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 8 | Clear Street Group Inc. | $970,439 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 9 | D. E. Shaw & Co., Inc. | $882,750 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
| 10 | Warberg Asset Management LLC | $856,603 | 2026-06-30 | SEC 13F filing | 2026-11-19 19:23 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/2000775.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0002000775. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.